US equities
|
SPCX
$167.12
▲+5.13%
NVDA
$237.22
▲+1.40%
MU
$1,064.84
▼-0.93%
TSLA
$377.80
▲+1.94%
MSFT
$525.92
▲+1.62%
INTC
$116.58
▼-2.30%
SNDK
$1,713.17
▼-0.40%
META
$745.43
▲+2.38%
SPCX
$167.12
▲+5.13%
NVDA
$237.22
▲+1.40%
MU
$1,064.84
▼-0.93%
TSLA
$377.80
▲+1.94%
MSFT
$525.92
▲+1.62%
INTC
$116.58
▼-2.30%
SNDK
$1,713.17
▼-0.40%
META
$745.43
▲+2.38%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
MaxCyte, Inc. - Common Stock
(NQ:
MXCT
)
1.080
+0.010 (+0.93%)
Delayed Quote
Updated: 11:15 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MaxCyte, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
↗
August 22, 2021
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 02, 2021
Gainers Exicure (NASDAQ:XCUR) stock moved upwards by 35.55% to $1.83 during Monday's pre-market session. The company's market cap stands at $161.0 million....
Via
Benzinga
London-Listed MaxCyte Makes NASDAQ Debut Today
↗
July 30, 2021
MaxCyte Inc (NASDAQ: MXCT) is already trading on London’s AIM, but now, it debuted on NASDAQ after pricing a $176 million IPO at $13 apiece, on the higher end of...
Via
Benzinga
Topics
Initial Public Offering
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
↗
August 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
↗
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
63 Biggest Movers From Friday
↗
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
